Ajanta Pharma Ltd

Desk›Healthcare› Ajanta Pharma Ltd

BSE 532331 · NSE AJANTPHARM · ISIN INE031B01049 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹3,540.70

-0.13%

BSE close, 28 August 2026

Market cap

₹44,244.24 cr

12.5 cr shares · Mid cap

Free float

₹16,098.98 cr

as published

P/E · P/B

43.9× · 12.53×

EPS ₹80.63 · BV ₹282.58

FY25-26 rev / PAT

4,845.92 / 946.82

₹ cr, as filed

Filings, window

4 selected · 15%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

Against 52-week high	-6.7%
Against 52-week low	+51.6%
Day change	-0.13%
Size band	Mid cap
Index membership	NIFTY 500

Valuation as published by BSE

Earnings per share	₹80.63
Price / earnings	43.91×
Price / book	12.53×
Book value — derived, price ÷ P/B	₹282.58
Return on equity	28.54%
Operating margin	31.41%
Net margin	21.19%

Consistency check

P/B ÷ P/E, which must equal ROE: 28.54%
ROE as published: 28.54%

Results ₹ crore, as filed

Jun-26 · Q

Mar-26 · Q

FY25-26

RevenueNet profit one scale across all three periods, ₹ crore

Period	Revenue ₹cr	Net profit ₹cr	EPS ₹	OPM	NPM
Jun-26 · Q	1,488.67	315.47	25.25	31.41%	21.19%
Mar-26 · Q	1,210.53	197.28	15.79	24.87%	16.30%
FY25-26	4,845.92	946.82	75.79	28.94%	19.54%

Quarter on quarter

Revenue, quarter on quarter: +23.0%
Net profit, quarter on quarter: +59.9%
Operating margin, quarter on quarter: +654 bps

Disclosure profile 26 filings in the window

Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Tag	Filings
Selected
Board Outcome	1
Concall Transcript	1
Dividend	1
Results	1
Selected sub-total	4
Procedural
SAST	8
Analyst / Investor Meet	3
General	3
Board Meeting	2
Newspaper Publication	2
Compliance Certificate	1
ESOP Allotment	1
Record Date	1
Trading Window	1
Procedural sub-total	22
Total	26

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

26 filings · 4 selected · busiest 2026-07-30

Filing rhythm · the twelve most recent

2026-08-142026-10-07

SelectedProcedural

Filings

26 in the window · 21 earlier on record

7 October 2026 · 13:52 IST

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pls find enclosed Certificate as per Reg 74(5) of SEBI (DP) Regulations.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
6 October 2026 · 10:32 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 06, 2026 for Aayush Agrawal, trustee ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
1 October 2026 · 13:10 IST

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
30 September 2026 · 09:27 IST

General

Submission Of Sustainability Report For FY 2026

Pls find enclosed herewith Sustainability Report for FY 2026.

Company Update / General View filing →
28 September 2026 · 09:23 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 28, 2026 for Aayush Agrawal, ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
25 September 2026 · 09:45 IST

Trading Window

Closure of Trading Window

Pls find enclosed herewith closure of trading window intimation

Insider Trading / SAST / Closure of Trading Window View filing →
18 September 2026 · 16:31 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 18, 2026 for Aayush Agrawal, ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
31 August 2026 · 11:44 IST

General

Participation In Investor Conference

Pls find enclosed Intimation w.r.t Participation in Investor Conference.

Company Update / General View filing →
31 August 2026 · 10:13 IST

Newspaper Publication

Newspaper Publication

Pls find enclosed newspaper publication for transfer of equity shares to IEPF.

Company Update / Newspaper Publication View filing →
27 August 2026 · 15:31 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 27, 2026 for Aayush Agrawal, trustee ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
19 August 2026 · 17:41 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 19, 2026 for Ravi Agrawal, trustee ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
14 August 2026 · 12:50 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Ravi Agrawal, trustee ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
5 August 2026 · 16:55 IST

General

Participation In Investor Conference

Pls find enclosed Intimation w.r.t participation in Investor Conference

Company Update / General View filing →
3 August 2026 · 16:27 IST

Concall Transcript

Earnings Call Transcript

Pls find enclosed herewith Earning Call Transcript

Company Update / Earnings Call Transcript View filing →
31 July 2026 · 12:19 IST

Newspaper Publication

Newspaper Publication

Pls find enclosed newspaper publication of financial results for the quarter ended 30.06.2026.

Company Update / Newspaper Publication View filing →
30 July 2026 · 17:38 IST

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Pls find enclosed Audio Recording of Earnings Call

Company Update / Analyst / Investor Meet View filing →
30 July 2026 · 14:51 IST

ESOP Allotment

Allotment of ESOP / ESPS

Pls find enclosed ESOP Allotment

Company Update / Allotment of ESOP / ESPS View filing →
30 July 2026 · 14:43 IST

Record Date

Record Date Intimation For Dividend

PFA record date intimation

Corp. Action / Record Date View filing →
30 July 2026 · 14:42 IST

Dividend

Corporate Action-Board approves Dividend

PFA Dividend Intimation

Corp. Action / Dividend View filing →
30 July 2026 · 14:38 IST

Results

Results For 30.06.2026

Results of 30.06.2026.

Result / Financial Results View filing →
30 July 2026 · 14:35 IST

Board Outcome

Board Meeting Outcome for BM Outcome

Board Meeting Outcome

Board Meeting / Outcome of Board Meeting View filing →
29 July 2026 · 12:23 IST

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 29, 2026 for Aayush Agrawal, trustee ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
21 July 2026 · 13:49 IST

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Pls find enclosed Revised Investor Call Intimation

Company Update / Analyst / Investor Meet View filing →
20 July 2026 · 14:53 IST

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Pls fine enclosed Investor Call Intimation

Company Update / Analyst / Investor Meet View filing →
20 July 2026 · 10:51 IST

Board Meeting

Update on board meeting

Ajanta Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Update on board meeting

Board Meeting / Board Meeting View filing →
20 July 2026 · 10:43 IST

Board Meeting

Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026.

Ajanta Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Financial Results for the quarter ....

Board Meeting / Board Meeting View filing →

RSS feed for Ajanta Pharma Ltd · the 50 most recent filings

Price
Market cap
Sector
Index
PE
Latest quarter revenue
Net profit
Filings in the window